Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 8, 1999, Pages 2854-2861

  Riches, F M ^a   Watts, G F ^a,b   Hua, J ^b   Stewart, G R ^a   Naoumova, R P ^c   Barrett, P H R ^d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d University of Washington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; CHOLESTEROL; INSULIN; INTERMEDIATE DENSITY LIPOPROTEIN; LATHOSTEROL; LEUCINE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DIET THERAPY; HUMAN; INSULIN BLOOD LEVEL; LIPID ANALYSIS; LIPOLYSIS; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; OBESITY; PRIORITY JOURNAL; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; TURNOVER TIME; VISCERA; WEIGHT REDUCTION;

EID: 0033320633     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.8.2854     Document Type: Article

References (53)

1. Abdominal fat distribution and disease: An overview of epidemiological data
2. Biology of regional fat distribution: Relationship to non-insulin dependent diabetes
3. Regional distribution of body fat, plasma lipoproteins and cardiovascular disease
4. Relation of abdominal obesity of hyperinsulinemia and high blood pressure in men
5. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity
6. Recent progress in understanding apolipoprotein B
7. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec Cardiovascular Study
8. 'Portal' adipose tissue as a generator of risk factors for cardiovascular disease and diabetes
9. Role of insulin resistance in human disease
10. Substrate delivery as a determinant of hepatic apoB secretion
11. Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes
12. Insulin regulates apolipoprotein B turnover and phosphorylation in rat hepatocytes
13. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals
14. Acute hyperinsulinaemia decreases hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in normolipidaemic, non-diabetic subjects
15. Acute hyperinsulinaemia decreases cholesterol synthesis less in subjects with non-insulin-dependent diabetes mellitus than in non-diabetic subjects
16. Role of cholesterol in regulating apolipoprotein B secretion by the liver
17. Direct association between the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 and plasma mevalonic acid and lathosterol concentrations in man
18. Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotien B-100 in normolipidaemic subjects
19. Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester
20. ApoB-100 secretion by HepG2 cells is regulated by the rate of triglyceride biosynthesis but not by intracellular lipid pools
21. Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia
22. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: Normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia
23. Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients and patients with coronary heart disease
24. Influence of obesity on the metabolism of apolipoprotein B in humans
25. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects: Effect of weight loss
26. How to assess exercise habits and physical fitness
27. International criteria for the diagnosis of diabetes and impaired glucose tolerance
28. Homeostasis model assessment: Insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man
29. Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B
30. Tracer-to-tracee ratio for analysis of stable isotope tracer data: Link with radioactive kinetic formalism
31. The complete structure of human apolipoprotein B-100 and its messenger RNA
32. Comparison of immunoturbidimetric and Lowry methods for measuring concentration of very low density lipoprotein apolipoprotein B-100 in plasma
33. Recommended methods of measurement of red-cell and plasma volume
34. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
35. Analysis of native and oxidized low-density lipoprotein oxysterols using gas chromatography-mass spectrometry with selective ion monitoring
36. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia
37. Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes
38. Quantification of adipose tissue by MRI: Relationship with anthropometric variables
39. Abdominal obesity and the development of non insulin-dependent diabetes mellitus
40. Regional differences in the control of lipolysis in human adipose tissue
41. Regulation of apoB secretion from HepG2 cells: Evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge
42. Assembly and secretion of hepatic very-low-density lipoproteins
43. Translocation of apolipoprotein B across the endoplasmic reticulum is blocked in abetalipoproteinemia
44. Mutations at the lipoprotein lipase gene locus in subjects with diabetes mellitus, obesity and lipaemia
45. Regulation of low-density lipoprotein receptors: Implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis
46. In vivo stimulation of low-density lipoprotein degradation by insulin
47. Hormonal regulation of low-density-lipoprotein (LDL) receptor activity in human hepatoma cells. Insulin increases LDL receptor activity and diminishes its suppression by exogenous LDL
48. Regulation of low-density-lipoprotein receptor mRNA by insulin in human hepatoma HepG2 cells
49. Plasma lipoproteins and lipase and lecithin:Cholesterol acyltransferase activities in obese subjects before and after weight reduction
50. Glucose clamp technique: A method for quantifying insulin secretion and resistance
51. Is insulin regulation of VLDL production defective in insulin resistance?
52. Low-density lipoprotein heterogeneity
53. Modes of action of lipid-lowering diets in man: Studies of apolipoprotein B kinetics in relation to fat consumption and dietary fatty acid composition